Moreover, the available data of correlations among IRF5, CCAT1, and miR-375 and HCC patient survival were scarce and the public datasets had little such information thus far, although the differential expressions of these molecules between HCC tumor and normal tissues have been shown and associated with the prognosis, and patient survival (27), and have acted as potential biomarkers in diagnosis and prognosis of HCC (11, 12, 60). This evidence concerns the gene IRF5 and hepatocellular carcinoma.